Resources
About Us
Meticulous Research®—a leading global market research company, published a research report titled “Antimicrobial Susceptibility Testing Market Size, Share, Forecast, & Trends Analysis by Product (Susceptibility Disks, Plates, MIC Strip) Test Type (Antibacterial, Antifungal) Method (Diffusion, Automated) Application End User—Global Forecast to 2031.”
According to this latest publication from Meticulous Research®, the antimicrobial susceptibility testing market is expected to reach $7.21 billion by 2031, at a CAGR of 6.7% during the forecast period. The growth of this market is primarily driven by the growing risk of infectious diseases, rising incidences of infections due to antimicrobial-resistant pathogens, and growing concerns related to antimicrobial resistance globally. Moreover, supportive initiatives and funding for research in the area of AMR also support market growth. Furthermore, active R&D to develop rapid antimicrobial susceptibility testing and growth prospects in emerging markets are offering market opportunities.
Key Players
The key players profiled in the antimicrobial susceptibility testing market report are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories Pvt. Ltd. (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China).
The global antimicrobial susceptibility testing market is segmented by Product (Manual AST Products {Susceptibility Disks, Susceptibility Plates, and MIC Strips}, Consumables, and Automated AST Products), Method (Disk Diffusion, Automated AST, Dilution, and Other Methods), Test Types (Antibacterial Tests, Anti-parasitic Tests, Antifungal Tests, and Other Test Types), Application (Clinical Diagnostics, Drug Discovery, and Development, Other Applications), End User (Diagnostic Laboratories & Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Institutes), Geography. The study also evaluates industry competitors and analyzes their market share at a global and regional level.
Among all the products covered in the report, in 2024, the manual antimicrobial susceptibility testing products segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The large market share of this segment is driven by the low cost of manual AST products and simple handling procedures. The availability of a diverse range of consumables for manual testing and easy interpretation of tests are supporting market growth.
Among all the methods covered in the report, in 2024, the disk diffusion segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The low cost associated with performing AST testing through the disk diffusion method and developments in the disk diffusion method with the use of automated technology is primarily supporting the segment’s large share. The disk diffusion method (also called the Kirby-Bauer method) is among the most flexible susceptibility testing methods used in clinical settings. This method is simple and practical and offers flexibility for the compounds being tested cost-effectively. It offers qualitative and interpretative results. Disk tests can be performed with Mueller-Hinton agar, which is available from multiple manufacturers and can be used with little or no requirement for additional instrumentation (e.g., calipers, a ruler, and an incubator). This makes it the least costly of all susceptibility methods.
Among all the test types studied in the report, in 2024, the antibacterial tests segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The large market share of this segment is attributed to the higher use of antibacterial tests in clinical diagnosis, the growing incidence of bacterial infections, the emergence of antibiotic-resistant bacteria, cost-effectiveness, simple and fast interpretation, and ease of use and availability.
Among all the applications studied in the report, in 2024, the clinical diagnostics segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The large market share of this segment is attributed to the rising burden of antimicrobial resistance and growing awareness about the use of antimicrobial susceptibility testing methods.
Among all the end users studied in the report, in 2024, the diagnostic laboratories and hospitals segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The large market share of this segment is attributed to the availability of well-equipped facilities and trained/skilled technicians, the rise in hospital-acquired infections, and initiatives taken by key players to offer AST products through diagnostic laboratories & hospitals.
Geographic Review
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America, and the Middle East & Africa. North America is expected to account for the largest share of the antimicrobial susceptibility testing market in 2024, followed by Europe and Asia-Pacific. Factors driving the North American market include the adoption of technologically advanced susceptibility testing methods and continuous research for new drugs using ASTs, along with awareness about treatment options. Favorable government initiatives also support the growth of the North America market. For instance, in October 2020, the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020–2025, was designed for coordinated, strategic actions to improve the health and well-being of all Americans by changing the course of antibiotic resistance.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5062
Key questions answered in the report-
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Kenya IVD Market to be Worth $68.66 Billion by 2032
Read More
Cardiac Biomarkers Market to be Worth $10.08 Billion by 2031
Read More
Cytogenetics Market to be Worth $5.5 Billion by 2031
Read More
Metagenomics Market to be Worth $ 6.71 Billion by 2031
Read More
Dental Lasers Market to be Worth $618.7 million by 2032
Read More
Bakuchiol Serum Market to Reach $4.41 Million by 2032
Read More
Burn Care Market to be Worth $4.32 Billion by 2032
Read More
Africa Medical Devices Market to be Worth $7.14 Billion by 2032
Read More
Middle East Medical Devices Market to be Worth $8.8 Billion by 2032
Read More
Surgical Drills Market to be Worth $1.71 Billion by 2032
Read More
Tissue Engineering Market to reach $7.41 Billion by 2032
Read More
Dental Prosthetics Market to be Worth $ 19.6 Billion by 2032
Read More
Whole Genome Sequencing Market to be Worth $7.17 Billion by 2031
Read More
IVD Assay Development Market to be Worth $8.39 Billion by 2031
Read More
Neurogenomics Market to Reach $4.68 Billion by 2031
Read More
India VNA & PACS Market to Reach $341.6 Million by 2031
Read More
China Microarray Market to Be Worth $910.4 Million by 2031
Read More
China Neurogenomics Market to Reach $562.1 Million by 2031
Read More
ELISA Market to be Worth $32.69 Billion by 2032
Read More
DNA Sequencing Market to be Worth $21.30 Billion by 2031
Read More
Oral Care Market to be Worth $70 Billion by 2032
Read More
Spirometer Market to be Worth $1.80 Billion by 2032
Read More
Viral Vaccines Market to be Worth $64.18 Billion by 2031
Read More
Pet Care Market to be Worth $287.96 Billion by 2032
Read More
Regenerative Medicine Market to be Worth $37.27 Billion by 2031
Read More
Hemostats Market to be Worth $5.32 Billion by 2032
Read More
Bioreactors Market to be Worth $39.96 Billion by 2032
Read More
Protein Assays Market to be Worth $4.36 Billion by 2032
Read More
Veterinary API Market to Reach $15.84 Billion by 2031
Read More
Asia-Pacific NGS Automation Market to be Worth $371 Million by 2032
Read More
Latin America NGS Market to be Worth $765.2 Million by 2032
Read More
Biochemical Reagents Market to be Worth $39.61 Billion by 2032
Read More
Microarray Kits Market to be Worth $2.51 Billion by 2032
Read More
Antibody Production Market to Reach $58.35 Billion by 2032
Read More
Middle East IVD Market to be Worth $2.15 Billion by 2032
Read More
Spatial Genomics Market to be Worth $3.23 Billion by 2031
Read More
Asia-Pacific IVD Market to be Worth $36.02 Billion by 2032
Read More
Europe NGS Market to be Worth $6.40 Billion by 2032
Read More
Lab Automation Market to be Worth $11.31 Billion by 2031
Read More
Bioinformatics Market to Reach $31.71 Billion by 2031
Read More
Europe IVD Market to be Worth $39.77 Billion by 2032
Read More
Sequencing Kits Market to be Worth $25.29 Billion by 2031
Read More
Veterinary API Market to Reach $15.84 Billion by 2032
Read More
U.S. Ambulatory EHR Market to be Worth $3.97 Billion by 2031
Read More
Sample Preparation Market to be Worth $12.77 Billion by 2031
Read More
Surgical Robots Market Worth $25.47 Billion by 2032
Read More
Medical Coatings Market Worth $3.32 Billion by 2032
Read More
Digital Therapeutics Market to be Worth $56.34 Billion by 2031
Read More
Liquid Handling Systems Market Worth $6.99 Billion by 2029
Read More
Electrosurgery Market to be Worth $8.99 Billion by 2031
Read More
Radiation Dose Management Market Worth $749.1 Million by 2029
Read More
Molecular Diagnostics Market Worth $46.69 Billion by 2030
Read More
Newborn Screening Market to be Worth $2.69 Billion by 2031
Read More
Pharmacogenomics Market to be Worth $19.5 Billion by 2031
Read More
Dental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read More
Nepal IVD Market Worth $62.7 Million by 2029
Read More
Pharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read More
Indonesia IVD Market Worth $1.11 Billion by 2029
Read More
Medical Waste Management Market Worth $17.02 billion by 2030
Read More
Empty Capsules Market Worth $4.47 Billion by 2029
Read More
Clear Aligners Market to be worth $18.8 Billion by 2030
Read More
HLA Typing Market Worth $1.9 Billion by 2029
Read More
Real-world Data Market Worth $1.66 billion by 2029
Read More
Track and Trace Solutions Market Worth $27.27 billion by 2029
Read More
Surface Disinfectant Market Worth $9.52 Billion by 2029
Read More
Electronic Lab Notebook Market Worth $787.7 million by 2029
Read More
Rapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read More
Plasma Therapy Market Worth $882.5 Million by 2028
Read More
Peripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read More
Biomaterials Market to Reach 128.7 Billion USD by 2023
Read More
Vaccine Storage Equipment Market Worth $1.83 billion by 2027
Read More
Plasma Fractionation Market Worth $46.9 Billion by 2029
Read More
Home Healthcare Market to be Worth $514.5 Billion by 2030
Read More
Cardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read More
European Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read More
Competent Cells Market Worth 2,318.6 Million USD By 2023
Read More
Cancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read More
Multimodal Imaging Market Worth $1.6 Billion By 2024
Read More
Pulse Lavage Market to be Worth $661.1 Million by 2030
Read More
Medical Cooling Systems Market Worth $2.8 Billion By 2024
Read More
Tissue Diagnostics Market Worth $8.52 Billion by 2029
Read More
Endoscopy Equipment Market Worth $59.8 Billion by 2029
Read More
African Forensic DNA Testing Market Worth $136.3 Million by 2025
Read More
Clinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read More
Infection Control Market Worth $58.2 Billion by 2027
Read More
Sleep Apnea Devices Market Worth $12.9 billion by 2027
Read More
Medical 3D Printing Market To Reach $983.2 Million By 2020
Read More
Genomics Market to be Worth $70.52 Billion by 2031
Read More
Analytical Standards Market Worth $2.66 Billion By 2027
Read More
Sterilization Equipment Market to be Worth $34.2 Billion by 2035
Read More
Telehealth Market Worth $539.73 Billion by 2029
Read More
Cell Culture Market Worth $48.63 Billion by 2029
Read More
Antimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read More
Flow Cytometry Market Worth $6.4 Billion by 2027
Read More
Medical Aesthetics Market Worth $29.43 billion by 2029
Read More
Oligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read More
In Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read More
Dental Implants Market Worth $6.52 Billion by 2029
Read More
Active Implantable Devices Market Worth 24.02 Billion USD By 2022
Read More
Ventilators Market to be Worth $13.23 Billion by 2031
Read More
Dialysis Market to be Worth $36.6 Billion by 2031
Read More
Task Trainers Market to Be Worth $2.9 Billion by 2032
Read More
Plasmapheresis Market to be Worth $2.55 Billion by 2030
Read More
Diabetes Care Devices Market Worth $31.9 Billion by 2028
Read More
Clinical Genomics Market Worth 879.0 Million USD By 2023
Read More
IVD Quality Control Market to be Worth $2.28 Billion by 2031
Read More
Laboratory Informatics Market Worth $6.1 Billion by 2030
Read More
Chromatography Data Systems Market to be Worth $1.7 billion by 2030
Read More
Bone Growth Stimulators Market Worth $1.94 Billion by 2030
Read More
Digital Diabetes Market worth $12.03 billion by 2025
Read More
Trocars Market Worth $968.5 Million by 2024
Read More
Healthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read More
Europe Hospital Beds Market to be Worth $2.09 Billion by 2030
Read More
Immunoassay Market Worth $46.49 Billion by 2028
Read More
Hospital Beds Market to Reach $7.09 Billion by 2031
Read More
Urinalysis Market Worth $2.19 billion by 2027
Read More
Medical Image Management Market Worth $7.22 billion by 2030
Read More
Breast Imaging Market Worth $7.08 Billion by 2027
Read More
VNA & PACS Market to be Worth $6.50 Billion by 2031
Read More